Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr;93(4):1850-1851.
doi: 10.1002/jmv.26549. Epub 2020 Oct 7.

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19

Francesco Drago  1   2 , Giulia Ciccarese  1 , Alfredo Rebora  2 , Aurora Parodi  1   2
Affiliations
Case Reports

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19

Francesco Drago et al. J Med Virol. 2021 Apr.
No abstract available

Keywords: SARS-CoV-2 infection; pityriasis rosea; viral reactivation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
Erythematous macules and petechiae on the hard and soft palate
See this image and copyright information in PMC

Comment in

  • Pityriasis rosea and COVID-19.
    Veraldi S, Spigariolo CB. Veraldi S, et al. J Med Virol. 2021 Jul;93(7):4068. doi: 10.1002/jmv.26679. Epub 2020 Dec 1. J Med Virol. 2021. PMID: 33205836 Free PMC article. No abstract available.

References

    1. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183(1):71‐77. 10.1111/bjd.19163 - DOI - PMC - PubMed
    1. Martín Enguix D, Salazar Nievas MDC, Martín Romero DT. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID‐19. Med Clín. 2020. 10.1016/j.medcle.2020.05.017 - DOI - PMC - PubMed
    1. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection. J Eur Acad Dermatol Venereol. 2020;34(9):e436‐e437. 10.1111/jdv.16579 - DOI - PMC - PubMed
    1. Watanabe T, Kawamura T, Aquilino EA, et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus‐7 and human herpesvirus‐6. J Invest Dermatol. 2002;119(4):793‐797. 10.1046/j.1523-1747.2002.00200.x - DOI - PubMed
    1. Nowak DM, Sordillo EM, Gitman RM, Paniz Mondolfi AE. Co‐infection in SARS‐CoV‐2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol. 2020;92(10):1699‐1700. 10.1002/jmv.25953 - DOI - PMC - PubMed

MeSH terms

Substances